| abstract |
The present disclosure provides a method of treating a subject identified as having an oncogene-induced cancer, the method comprising an agent targeting the extracellular production of adenosine and/or activation of a receptor of one of its receptors by adenosine and administering an agent that antagonizes to the subject. |